TENAX THERAPEUTICS, INC. Increase (Decrease) in Inventories
TENAX THERAPEUTICS, INC. (TENX) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2017-03-16
- TENAX THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2015-04-30 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2015-01-31 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2014-04-30 was -$97.44K, a 298.08% decline year-over-year.
- TENAX THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2014-01-31 was -$2.99K, a 310.43% decline year-over-year.
- TENAX THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2016 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2015 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2014 was -$99.20K, a 590.43% decline from fiscal 2013.
- TENAX THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2013 was $20.23K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 8 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed | Increase (Decrease) in Inventories 530 month | Increase (Decrease) in Inventories 533 month | Increase (Decrease) in Inventories 536 month | Increase (Decrease) in Inventories 539 month | Increase (Decrease) in Inventories 542 month | Increase (Decrease) in Inventories 545 month | Increase (Decrease) in Inventories 554 month | Increase (Decrease) in Inventories 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 | ||||||||||||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 | ||||||||||||||
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 | ||||||||||||
| 2015-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $0.00 10-Q · filed 2015-03-17 | |||||||||||||
| 2014-10-31 | $0.00 10-Q · filed 2014-12-15 | ||||||||||||||
| 2014-04-30 | -$97.44K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$100.42K derived: sum of 2 quarters · filed 2017-03-16 | -$99.47K derived: sum of 3 quarters · filed 2017-03-16 | -$99.20K 10-K · filed 2017-03-16 | $99.20K 10-K · filed 2014-07-29 | ||||||||||
| 2014-01-31 | -$2.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -$2.04K derived: sum of 2 quarters · filed 2015-03-17 | -$1.77K 10-Q · filed 2015-03-17 | $1.77K 10-Q · filed 2014-03-17 | $47.42K derived: sum of 4 quarters · filed 2016-03-14 | $212.28K 10-Q · filed 2014-03-17 | |||||||||
| 2013-10-31 | $951.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $1.22K 10-Q · filed 2014-12-15 | $50.41K derived: sum of 3 quarters · filed 2016-03-14 | $51.83K derived: sum of 4 quarters · filed 2016-03-14 | $211.74K 10-Q · filed 2013-12-17 | ||||||||||
| 2013-07-31 | $268.00 10-Q · filed 2014-09-15 | $49.46K derived: sum of 2 quarters · filed 2016-03-14 | $50.88K derived: sum of 3 quarters · filed 2016-03-14 | $55.66K derived: sum of 4 quarters · filed 2016-03-14 | $210.79K 10-Q · filed 2013-09-17 | ||||||||||
| 2013-04-30 | $49.19K derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | $50.61K derived: sum of 2 quarters · filed 2016-03-14 | $55.39K derived: sum of 3 quarters · filed 2016-03-14 | $20.23K 10-KT · filed 2016-03-14 | -$20.23K 10-K · filed 2013-06-26 | $210.52K 10-K · filed 2013-06-26 | |||||||||
| 2013-01-31 | $1.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $6.20K derived: sum of 2 quarters · filed 2014-03-17 | -$28.96K 10-Q · filed 2014-03-17 | $4.37K derived: sum of 4 quarters · filed 2014-03-17 | $201.78K 10-Q · filed 2013-03-18 | ||||||||||
| 2012-10-31 | $4.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-17 | -$30.38K 10-Q · filed 2013-12-17 | $2.96K derived: sum of 3 quarters · filed 2013-12-17 | -$18.03K derived: sum of 4 quarters · filed 2013-12-17 | $200.37K 10-Q · filed 2012-12-14 | ||||||||||
| 2012-07-31 | -$35.16K 10-Q · filed 2013-09-17 | -$1.82K derived: sum of 2 quarters · filed 2013-09-17 | -$22.81K derived: sum of 3 quarters · filed 2013-09-17 | -$64.84K derived: sum of 4 quarters · filed 2013-09-17 | $195.59K 10-Q · filed 2012-09-19 | ||||||||||
| 2012-04-30 | $33.34K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $12.35K derived: sum of 2 quarters · filed 2013-06-26 | -$29.68K derived: sum of 3 quarters · filed 2013-06-26 | -$7.28K 10-K · filed 2013-06-26 | $230.75K 10-K · filed 2012-07-25 | ||||||||||
| 2012-01-31 | -$20.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | -$63.01K derived: sum of 2 quarters · filed 2013-03-18 | -$40.62K 10-Q · filed 2013-03-18 | $111.43K derived: sum of 4 quarters · filed 2013-03-18 | $197.41K 10-Q · filed 2012-03-15 | ||||||||||
| 2011-10-31 | -$42.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | -$19.63K 10-Q · filed 2012-12-14 | $132.42K derived: sum of 3 quarters · filed 2012-12-14 | $166.03K derived: sum of 4 quarters · filed 2012-12-14 | $218.40K 10-Q · filed 2011-12-15 | ||||||||||
| 2011-07-31 | $22.40K 10-Q · filed 2012-09-19 | $174.45K derived: sum of 2 quarters · filed 2012-09-19 | $208.06K derived: sum of 3 quarters · filed 2012-09-19 | $162.49K derived: sum of 4 quarters · filed 2012-09-19 | $260.42K 10-Q · filed 2011-09-19 | ||||||||||
| 2011-04-30 | $152.05K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $185.66K derived: sum of 2 quarters · filed 2012-07-25 | $140.09K derived: sum of 3 quarters · filed 2012-07-25 | $238.03K 10-K · filed 2012-07-25 | |||||||||||
| 2011-01-31 | $33.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | -$11.96K derived: sum of 2 quarters · filed 2012-03-15 | $85.98K 10-Q · filed 2012-03-15 | ||||||||||||
| 2010-10-31 | -$45.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $52.36K 10-Q · filed 2011-12-15 | |||||||||||||
| 2010-07-31 | $97.94K 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |